Hula Therapeutics
Hula Therapeutics is a clinical-stage precision immunotherapy company focused on developing treatments for patients with solid cancers. Built on pioneering research from the lab of Dr. John Maris at the Children’s Hospital of Philadelphia (CHOP), Hula combines cutting-edge immunopeptidomics with novel protein engineering to unlock the previously untapped reservoir of tumor-specific, intracellular targets in solid cancers. Our approach is compatible with deploying multiple immunotherapies and is highly differentiated in its ability to deliver therapeutics to a broad distribution of HLA allotypes. Our lead program in neuroblastoma, HLTX-001, is a precision-engineered CAR-T therapy currently being evaluated in a Phase 1b clinical trial.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
0
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Hula Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Sign up to unlock all 1 contacts at Hula Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Hula Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.